Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL22345576

CCOC(=O)Cc1c[n+](C)nc2ccccc12.O=C([O-])C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.43
▸ ALDH1A1 P00352 6/20 0.40
▸ HPGD P15428 4/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ TOP2A P11388 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ AHR P35869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL22345557 0.78 HDAC6 (0.39) L3MBTL1KMT2ANPSR1PRNPTSHR
Trifluoroacetic Acid SCHEMBL22345475 0.78 TBXAS1 (0.34) TBXAS1ACHE
SCHEMBL22345559 0.72 CYP4F2 (0.34) KDM4EL3MBTL1MAPTTDP1MEN1
SCHEMBL6174947 0.68 PKM (0.54) PKMALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL22345536 0.68 NR1I2 (0.37) ALDH1A1HPGDKDM4EMAPTMEN1
SCHEMBL22345556 0.67 PKM (0.52) PKMALDH1A1HPGDKDM4EL3MBTL1
Iodide SCHEMBL22345444 0.67 KDM4E (0.46) ALDH1A1HPGDKDM4EMAPTTDP1
Trifluoroacetic Acid SCHEMBL29564265 0.67 BBOX1 (0.41) KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL22345526 0.66 NPY5R (0.43) HPGDKDM4EMAPTMEN1KMT2A
SCHEMBL68340 0.66 PKM (0.60) PKMALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
EP-3924344-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH Syngenta Crop Protection AG (CH) 2021-12-22 — — EP disclosed
CN-113423694-A Cinnolinium compounds for use in a method for controlling unwanted plant growth 先正达农作物保护股份公司 2021-09-21 — — CN disclosed
WO-2020164970-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2020-08-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH NOTUM, DDT, CYP51A1 PKM 2720/4885ALDH1A1 244/4885HPGD 555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback